Close Menu

NEW YORK – Genome Diagnostics (GenDx) announced Thursday that it has completed CE marking of its NGSgo-MX6-1 and NGSgo-AmpX v2 HLA typing products.

NGSgo-MX6-1 is a newly developed multiplex amplification strategy combining amplification primers for six HLA genes in a single tube: HLA-A, B, C, DRB1, DQB1 and DPB1. According to the Utrecht, Netherlands-based firm, the product greatly reduces the number of pipetting steps and hands-on time.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.